[Efficacy of liposomal cytarabine in neoplastic meningitis].
Unità Operativa Neuro-Oncologia, Dipartimento di Oncologia, ASO San Giovanni Battista e Università di Torino.
Roberta
R
Rudà
Barbara
B
Leoncini
Elena
E
Laguzzi
Elisa
E
Trevisan
Daniele
D
Guarneri
Oscar
O
Bertetto
Riccardo
R
Soffietti
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007278:Injections, Spinal; D008081:Liposomes; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D010166:Palliative Care; D011446:Prospective Studies; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine